MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Utility of quantitative EEG during sleep as a potential biomarker of Lewy body disease progression

    E. Matar, K. Ehgoetz Martens, R. Grunstein, A. D'Rozario, S. Lewis (Sydney, Australia)

    Objective: Objective: To assess whether progression from isolated REM sleep behaviour disorder (iRBD), established Parkinson’s disease (PD) and Dementia with Lewy bodies (DLB) are accompanied…
  • 2023 International Congress

    Transcranical Pulse Stimulation in Parkinson’s rest tremor: a pilot study.

    P. Manganotti, M. Liccari, TMI. Lombardo, M. Michelutti, M. Catalan (Trieste, Italy)

    Objective: The goal of this paper is to explore a possible effect of TPS on the PD rest tremor circuit, stimulating the motor cortex (M1)…
  • 2023 International Congress

    Efficacy of emergency deep brain stimulation in the Globus pallidus pars interna (GPi-DBS) for dystonic storm in an adult patient with de novo GNAO1-Mutation

    V. Maltese (Würzburg, Germany)

    Objective: To report the efficacy of deep brain stimulation in the Globus pallidus pars interna (GPi-DBS) as rescue treatment of therapy-refractory dystonic storm in an…
  • 2023 International Congress

    Perception of the subjective visual vertical in subjects with cervical dystonia

    I. Reuter (Gießen, Germany)

    Objective: The Aim of the study was to assess:1.) if the perception of the visual vertical (VV) is impaired in subjects with cervical dystonia (CDsub),…
  • 2023 International Congress

    A newly implemented NGS-based method to detect GBA1 variants in patients with Parkinson’s disease

    E. Monfrini, I. Palmieri, G. Cuconato, M. Percetti, P. Cortelli, A. Di Fonzo, EM. Valente (Milano, Italy)

    Objective: We aim to implement a new cost-effective and reliable next-generation-sequencing-based technology to test GBA1 gene in Parkinson disease (PD) patients. Background: Heterozygous variants in the…
  • 2023 International Congress

    Screening risk of falls in Parkinson’s disease population living in underserved areas

    T. Capato, J. Miranda, F. Santos, R. Cury, E. Barbosa (São Paulo, Brazil)

    Objective: To verify the feasibility of the Balance-App to assess the risk of falls in the PD population living in underserved areas. Background: The screening…
  • 2023 International Congress

    The effect of continuous subcutaneous apomorphine infusion on vitamin B metabolites and plasma homocysteine in Parkinson’s disease patients

    O. Phokaewvarangkul, N. Kantachadvanich, R. Bhidayasiri (Bangkok, Thailand)

    Objective: To evaluate the plasma level of vitamin B and homocysteine between PD patients with conventional medications and PD patients with CSAI. Background: Although levodopa…
  • 2023 International Congress

    Double-blind, randomized, crossover clinical trial to compare VIM vs PSA deep brain stimulation in patients with disabling essential tremor. Preliminary results.

    L. Triguero-Cueva, CJ. Madrid Navarro, MJ. Perez Navarro, B. Iáñez Velasco, M. Jouma Katati, JP. Martínez Barbero, A. Mínguez-Castellanos, F. Escamilla Sevilla (Jódar, Spain)

    Objective: To compare the safety, efficacy, energy efficiency and quality of life (QoL) outcomes of bilateral PSA-DBS vs bilateral VIM-DBS in the treatment of refractory…
  • 2023 International Congress

    Levodopa-carbidopa intestinal gel for managing severe refractory tremors of idiopathic Parkinson’s disease: Case Series

    M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi governorate, Kuwait)

    Objective: To report our experience with the use of levodopa-carbidopa intestinal gel (LCIG) infusion therapy for the treatment of four patients with idiopathic Parkinson’s disease…
  • 2023 International Congress

    A comparison of national data on Parkinson’s disease mortality between the USA and UK

    N. Smati, W. Lintiso, E. Shamim (Gaithersburg, USA)

    Objective: To evaluate recent mortality trends in Parkinson’s Disease (PD) between the United States of America (USA) and the United Kingdom (UK) per national healthcare…
  • « Previous Page
  • 1
  • …
  • 88
  • 89
  • 90
  • 91
  • 92
  • …
  • 186
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley